Genomics Personalized Health Market 2027 by Technology, Test Type, End User and Geography | The Insight Partners

Genomics Personalized Health Market to 2027 - Global Analysis and Forecasts By Technology (NGS platforms, RT-PCR, Microarray, Genetic Analyzers); Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Others); End User (Academics & Research Institutes, Diagnostic Centers, Others) and Geography

Report Code: TIPRE00007153 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Genomic personalized medicine and surgery characterizes an innovative method for health care, which modifies patients' medical treatment as per their genetic information. The advanced technique is the result of improved knowledge of the human genome and methods this information can be useful for physicians in the medical and surgical managing their patients. These can further classify several complex diseases and lead to the detection of more specific treatments based on the genomic profiling, removing some conventional treatments that could verify unsuccessfully or have adverse side effects in particular patient populations.

MARKET DYNAMICS

Genomics personalized health market is anticipated to grow in the forecast period owing to driving factors such as an increase in the biopharmaceutical and healthcare industry and technological development. Moreover, growth in the prevalence of cancer, the surge in the geriatric population, and growing attentiveness towards health in emerging economies is also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Genomics Personalized Health Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of genomics personalized health market with detailed market segmentation by technology, test type, end user, and geography. The global genomics personalized health market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading genomics personalized health market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global genomics personalized health market is segmented on the basis of technology, test type and end user. Based on technology, the market is segmented as NGS platforms, RT-PCR, microarray, genetic analyzers. Based on test type, the market is segmented as oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, others. Based on end user, the market is segmented as academics & research institutes, diagnostic centers, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global genomics personalized health market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genomics personalized health market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting genomics personalized health market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genomics personalized health market in these regions.

MARKET PLAYERS

The report covers key developments in the genomics personalized health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from genomics personalized health market are anticipated to lucrative growth opportunities in the future with the rising demand for genomics personalized health in the global market. Below mentioned is the list of few companies engaged in the Genomics personalized health market.

The report also includes the profiles of key genomics personalized health market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  QIAGEN
  •  Illumina, Inc.
  •  Thermo Fisher Scientific, Inc.
  •  Bio-Rad Laboratories, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  Lonza
  •  Invitae Corporation
  •  Genetic Technologies Limited
  •  Eastern Biotech
  •  DNA Genotek Inc. (OraSure Technologies, Inc.)

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomics Personalized Health Market - By Technology
1.3.2 Genomics Personalized Health Market - By Test Type
1.3.3 Genomics Personalized Health Market - By End User
1.3.4 Genomics Personalized Health Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENOMICS PERSONALIZED HEALTH MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
5. GENOMICS PERSONALIZED HEALTH MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENOMICS PERSONALIZED HEALTH MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMICS PERSONALIZED HEALTH - GLOBAL MARKET OVERVIEW
6.2. GENOMICS PERSONALIZED HEALTH - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. NGS PLATFORMS
7.3.1. Overview
7.3.2. NGS platforms Market Forecast and Analysis
7.4. RT-PCR
7.4.1. Overview
7.4.2. RT-PCR Market Forecast and Analysis
7.5. MICROARRAY
7.5.1. Overview
7.5.2. Microarray Market Forecast and Analysis
7.6. GENETIC ANALYZERS
7.6.1. Overview
7.6.2. Genetic Analyzers Market Forecast and Analysis
8. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY TESTING
8.3.1. Overview
8.3.2. Oncology Testing Market Forecast and Analysis
8.4. INFECTIOUS DISEASE TESTING
8.4.1. Overview
8.4.2. Infectious Disease Testing Market Forecast and Analysis
8.5. ORPHAN DISEASE TESTING
8.5.1. Overview
8.5.2. Orphan Disease Testing Market Forecast and Analysis
8.6. AUTOIMMUNE DISEASE TESTING
8.6.1. Overview
8.6.2. Autoimmune Disease Testing Market Forecast and Analysis
8.7. OBSTETRICS TESTING
8.7.1. Overview
8.7.2. Obstetrics Testing Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. ACADEMICS & RESEARCH INSTITUTES
9.3.1. Overview
9.3.2. Academics & Research Institutes Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. GENOMICS PERSONALIZED HEALTH MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Genomics Personalized Health Market Overview
10.1.2 North America Genomics Personalized Health Market Forecasts and Analysis
10.1.3 North America Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.1.4 North America Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.1.5 North America Genomics Personalized Health Market Forecasts and Analysis - By End User
10.1.6 North America Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.1.6.1 United States Genomics Personalized Health Market
10.1.6.1.1 United States Genomics Personalized Health Market by Technology
10.1.6.1.2 United States Genomics Personalized Health Market by Test Type
10.1.6.1.3 United States Genomics Personalized Health Market by End User
10.1.6.2 Canada Genomics Personalized Health Market
10.1.6.2.1 Canada Genomics Personalized Health Market by Technology
10.1.6.2.2 Canada Genomics Personalized Health Market by Test Type
10.1.6.2.3 Canada Genomics Personalized Health Market by End User
10.1.6.3 Mexico Genomics Personalized Health Market
10.1.6.3.1 Mexico Genomics Personalized Health Market by Technology
10.1.6.3.2 Mexico Genomics Personalized Health Market by Test Type
10.1.6.3.3 Mexico Genomics Personalized Health Market by End User
10.2. EUROPE
10.2.1 Europe Genomics Personalized Health Market Overview
10.2.2 Europe Genomics Personalized Health Market Forecasts and Analysis
10.2.3 Europe Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.2.4 Europe Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.2.5 Europe Genomics Personalized Health Market Forecasts and Analysis - By End User
10.2.6 Europe Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Genomics Personalized Health Market
10.2.6.1.1 Germany Genomics Personalized Health Market by Technology
10.2.6.1.2 Germany Genomics Personalized Health Market by Test Type
10.2.6.1.3 Germany Genomics Personalized Health Market by End User
10.2.6.2 France Genomics Personalized Health Market
10.2.6.2.1 France Genomics Personalized Health Market by Technology
10.2.6.2.2 France Genomics Personalized Health Market by Test Type
10.2.6.2.3 France Genomics Personalized Health Market by End User
10.2.6.3 Italy Genomics Personalized Health Market
10.2.6.3.1 Italy Genomics Personalized Health Market by Technology
10.2.6.3.2 Italy Genomics Personalized Health Market by Test Type
10.2.6.3.3 Italy Genomics Personalized Health Market by End User
10.2.6.4 Spain Genomics Personalized Health Market
10.2.6.4.1 Spain Genomics Personalized Health Market by Technology
10.2.6.4.2 Spain Genomics Personalized Health Market by Test Type
10.2.6.4.3 Spain Genomics Personalized Health Market by End User
10.2.6.5 United Kingdom Genomics Personalized Health Market
10.2.6.5.1 United Kingdom Genomics Personalized Health Market by Technology
10.2.6.5.2 United Kingdom Genomics Personalized Health Market by Test Type
10.2.6.5.3 United Kingdom Genomics Personalized Health Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Genomics Personalized Health Market Overview
10.3.2 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis
10.3.3 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.3.5 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Genomics Personalized Health Market
10.3.6.1.1 Australia Genomics Personalized Health Market by Technology
10.3.6.1.2 Australia Genomics Personalized Health Market by Test Type
10.3.6.1.3 Australia Genomics Personalized Health Market by End User
10.3.6.2 China Genomics Personalized Health Market
10.3.6.2.1 China Genomics Personalized Health Market by Technology
10.3.6.2.2 China Genomics Personalized Health Market by Test Type
10.3.6.2.3 China Genomics Personalized Health Market by End User
10.3.6.3 India Genomics Personalized Health Market
10.3.6.3.1 India Genomics Personalized Health Market by Technology
10.3.6.3.2 India Genomics Personalized Health Market by Test Type
10.3.6.3.3 India Genomics Personalized Health Market by End User
10.3.6.4 Japan Genomics Personalized Health Market
10.3.6.4.1 Japan Genomics Personalized Health Market by Technology
10.3.6.4.2 Japan Genomics Personalized Health Market by Test Type
10.3.6.4.3 Japan Genomics Personalized Health Market by End User
10.3.6.5 South Korea Genomics Personalized Health Market
10.3.6.5.1 South Korea Genomics Personalized Health Market by Technology
10.3.6.5.2 South Korea Genomics Personalized Health Market by Test Type
10.3.6.5.3 South Korea Genomics Personalized Health Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Genomics Personalized Health Market Overview
10.4.2 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis
10.4.3 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.4.5 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Genomics Personalized Health Market
10.4.6.1.1 South Africa Genomics Personalized Health Market by Technology
10.4.6.1.2 South Africa Genomics Personalized Health Market by Test Type
10.4.6.1.3 South Africa Genomics Personalized Health Market by End User
10.4.6.2 Saudi Arabia Genomics Personalized Health Market
10.4.6.2.1 Saudi Arabia Genomics Personalized Health Market by Technology
10.4.6.2.2 Saudi Arabia Genomics Personalized Health Market by Test Type
10.4.6.2.3 Saudi Arabia Genomics Personalized Health Market by End User
10.4.6.3 U.A.E Genomics Personalized Health Market
10.4.6.3.1 U.A.E Genomics Personalized Health Market by Technology
10.4.6.3.2 U.A.E Genomics Personalized Health Market by Test Type
10.4.6.3.3 U.A.E Genomics Personalized Health Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Genomics Personalized Health Market Overview
10.5.2 South and Central America Genomics Personalized Health Market Forecasts and Analysis
10.5.3 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.5.5 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By End User
10.5.6 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Genomics Personalized Health Market
10.5.6.1.1 Brazil Genomics Personalized Health Market by Technology
10.5.6.1.2 Brazil Genomics Personalized Health Market by Test Type
10.5.6.1.3 Brazil Genomics Personalized Health Market by End User
10.5.6.2 Argentina Genomics Personalized Health Market
10.5.6.2.1 Argentina Genomics Personalized Health Market by Technology
10.5.6.2.2 Argentina Genomics Personalized Health Market by Test Type
10.5.6.2.3 Argentina Genomics Personalized Health Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENOMICS PERSONALIZED HEALTH MARKET, KEY COMPANY PROFILES
12.1. QIAGEN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-RAD LABORATORIES, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LONZA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INVITAE CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GENETIC TECHNOLOGIES LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EASTERN BIOTECH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DNA GENOTEK INC. (ORASURE TECHNOLOGIES, INC.)
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. QIAGEN
2. Illumina, Inc.
3. Thermo Fisher Scientific, Inc.
4. Bio-Rad Laboratories, Inc.
5. F. Hoffmann-La Roche Ltd
6. Lonza
7. Invitae Corporation
8. Genetic Technologies Limited
9. Eastern Biotech
10. DNA Genotek Inc. (OraSure Technologies, Inc.)